Most people have never heard of Prader-Willi syndrome. But for the families living it, every decision carries lifelong consequences. In this episode, I sit down with Alegna Cambra from Supreme Twins ...
WE’LL TALK TO YOU LATER. WELL, IMAGINE EATING ENOUGH MAYBE TOO MUCH, BUT NEVER FEELING FULL. THAT’S WHAT A NORTHLAND TODDLER LIVES WITH EVERY DAY. AND THIS WORLD WHERE DISEASE DAY CAME DECISIONS DONNA ...
When 15-year-old Anna Hankins accepted the title of Miss Amazing in Chicago, the Mississippi teen was beaming not only because of the award, but also because of the opportunity to raise awareness ...
Clinical Trials Arena on MSN
Aardvark gains IRB approval for ARD-101 trial to treat Prader-Willi syndrome
Aardvark intends to enrol 90 patients across Australia, Canada, South Korea, the UK, and the US.
A Prescription Drug User Fee Act target date of December 27, 2024 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application ...
A Little Britt of Fun on MSN
Every day is a struggle! In 2002, Katie Price gave birth to Harvey, a child who would later change her life completely.
Katie Price’s Son Harvey: Behind the Public Spotlight and Personal Challenges Harvey Price’s Ongoing Journey of Streng ...
Family genetics evaluations. Several family visits with the geneticist and subsequent laboratory evaluations revealed that Bobby had PWS. It was also established that his siblings did not have the ...
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the addition of a new Phase 3 development candidate to its rare disease portfolio, ACP-101 (intranasal carbetocin ...
SGLT2 inhibitors significantly improved glycaemic control and reduced the albumin-to-creatinine ratio without affecting body weight in patients with Prader-Willi syndrome and type 2 diabetes (T2D); ...
Soleno Therapeutics, Inc. announced its participation in the 2025 United In Hope: International Prader-Willi Syndrome Conference, scheduled for June 24-28, 2025, in Phoenix, AZ. The company will ...
-- Company recently completed a meeting with the FDA and plans to initiate a Phase 3 study in the fourth quarter of 2023 “Acadia’s acquisition of ACP-101 demonstrates our commitment to acquiring and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results